Accreditation Valid Until 03/03/2025
Please also watch the other modules from this session: IBD Immunology and Emerging Therapies, Small Molecules (JAKi/S1P agonists), IL-12/23 and IL-23 Receptor Antagonists, and the IBD Immunology and Emerging Therapies Q & A.